Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Another SVA reviewed publication!!

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jan 21, 2022 9:29am

206 Views

Post# 34341632

RE:RE:RE:RE:RE:RE:Another SVA reviewed publication!!

Sure if you think so. Call the company and find out. I know the answer, you sound a little unsure.

Mercuryfilling1 wrote: Really Bio? So the President & CEO of the company sponsering the study is "heavily involved" in choosing the patient(s)? That would be just plain weird and probably unethical.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?